MGP
TMO icon

Metis Global Partners’s Thermo Fisher Scientific TMO Stock Holding History

Metis Global Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.39M Sell
10,759
-663
-6% -$318K 0.12% 128
2026
Q1 		$5.61M Sell
11,422
-1,232
-10% -$669K 0.14% 122
2025
Q4 		$7.33M Sell
12,654
-3,963
-24% -$2.24M 0.17% 101
2025
Q3 		$8.06M Sell
16,617
-1,035
-6% -$482K 0.19% 87
2025
Q2 		$7.16M Sell
17,652
-5,841
-25% -$2.44M 0.18% 88
2025
Q1 		$11.7M Buy
23,493
+2,503
+12% +$1.36M 0.33% 46
2024
Q4 		$10.9M Sell
20,990
-316
-1% -$174K 0.33% 47
2024
Q3 		$13.2M Buy
21,306
+565
+3% +$334K 0.41% 42
2024
Q2 		$11.5M Sell
20,741
-78
-0.4% -$44.7K 0.39% 41
2024
Q1 		$12.1M Sell
20,819
-83
-0.4% -$46.6K 0.44% 39
2023
Q4 		$11.1M Buy
20,902
+2,828
+16% +$1.37M 0.44% 40
2023
Q3 		$9.15M Buy
18,074
+2,358
+15% +$1.26M 0.44% 36
2023
Q2 		$8.2M Sell
15,716
-90
-0.6% -$48.6K 0.44% 36
2023
Q1 		$9.11M Buy
15,806
+4,394
+39% +$2.48M 0.58% 28
2022
Q4 		$6.28M Buy
11,412
+4,145
+57% +$2.2M 0.56% 29
2022
Q3 		$3.69M Buy
7,267
+612
+9% +$342K 0.59% 28
2022
Q2 		$3.62M Buy
6,655
+437
+7% +$241K 0.58% 29
2022
Q1 		$3.67M Buy
6,218
+2,792
+81% +$1.6M 0.44% 32
2021
Q4 		$2.29M Buy
+3,426
New +$2.14M 0.64% 25

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Metis Global Partners's TMO Position: Q2 2026 in Review

Metis Global Partners reduced its Thermo Fisher Scientific (TMO) stake by 5.8% in Q2 2026, selling an estimated $318K and leaving 10,759 shares worth $5.39M. The position accounts for 0.12% of the portfolio, ranked #128.

Metis Global Partners first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $13.2M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Metis Global Partners held 10,759 shares of Thermo Fisher Scientific worth $5.39M as of Q2 2026.
  • Metis Global Partners sold 663 Thermo Fisher Scientific shares in Q2 2026, an estimated $318K.
  • Thermo Fisher Scientific made up 0.12% of Metis Global Partners's portfolio in Q2 2026, its #128 holding.
  • Metis Global Partners first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • Metis Global Partners's Thermo Fisher Scientific position peaked at $13.2M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.